Skip to main content
letter
. 2019 Sep 1;111(3):105–107. doi: 10.32074/1591-951X-19-19

Fig. 1.ABCD.

Fig. 1.ABCD

Metastatic CDX2-positive prostate adenocarcinoma, hematoxylin and eosin (H&E) and immunostains. (A) H&E (low power) with nuclear features in inset (high power); (B) CDX2 (high power); (C) NKX3.1 (high power); (D) PSA (high power).